Last reviewed · How we verify

NCT04599049

Evaluation Study on Smoke-free Teens Programme 2020-2021

Completed NA Last updated 25 October 2021
What this trial tests

NA trial testing six sessions of online classes and virtual training day camps through Zoom in two days in Smoking Cessation in 173 participants. Completed in 31 July 2021.

Timeline
30 October 2020
Primary endpoint
31 July 2021
31 July 2021

Quick facts

Lead sponsorThe University of Hong Kong
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment173
Start date30 October 2020
Primary completion31 July 2021
Estimated completion31 July 2021
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

The University of Hong Kong

Who can join

Adults 14 to 18, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objectives are: i. To evaluate Smoke-free Teens' change in knowledge on smoking hazards, attitudes towards smoking, tobacco control and smoking cessation, and practices for promoting smoking prevention and cessation, ii. To evaluate the process and quality of smoke-free programmes organized by the Smoke-free Teens in their schools/community, and iii. To measure the number of people reached in the smoke-free programmes organized by the Smoke-free Teens.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

Other The University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04599049.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing